Norris Perne & French LLP Medtronic PLC Transaction History

Norris Perne & French LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$87.4 - $113.09 $160,204 - $207,293	-1,833 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$100.58 - $112.38 $184,363 - $205,992	1,833 New	1,833 $203,000
Q4 2021 Jan 26, 2022	SELL	$99.53 - $127.75 $191,794 - $246,174	-1,927 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$122.75 - $135.17 $122 - $135	1 Added 0.05%	1,927 $242,000
Q2 2021 Jul 20, 2021	BUY	$118.19 - $131.5 $17,846 - $19,856	151 Added 8.51%	1,926 $239,000
Q1 2021 Apr 30, 2021	BUY	$111.18 - $119.74 $197,344 - $212,538	1,775 New	1,775 $210,000
Q1 2020 Apr 16, 2020	SELL	$72.92 - $121.3 $134,974 - $224,526	-1,851 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$104.49 - $114.54 $193,410 - $212,013	1,851 New	1,851 $210,000

2,289

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

Stay updated on Norris Perne & French LLP with notifications on news.